End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.43 CNY | +2.06% |
|
-1.67% | -29.26% |
29/04 | Triumph Science & Technology Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
19/04 | Mainland China and Hong Kong stocks fall on Middle East tensions | RE |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's profit outlook over the next few years is a strong asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 40.65 times its estimated earnings per share for the ongoing year.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Electronic Equipment & Parts
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-29.26% | 120.08Cr | - | ||
+27.71% | 3.31TCr | B+ | ||
+27.92% | 880.06Cr | B+ | ||
+0.35% | 420.24Cr | A | ||
-1.93% | 416.64Cr | A | ||
-9.97% | 387.7Cr | B+ | ||
-18.52% | 379.37Cr | - | - | |
+0.89% | 332.25Cr | - | D | |
-31.64% | 240.75Cr | C+ | ||
-29.75% | 154.35Cr | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 600552 Stock
- Ratings Triumph Science & Technology Co.,Ltd